Dapagliflozin and Anemia in Patients with Chronic Kidney Disease
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Dapagliflozin and Anemia in Patients with Chronic Kidney Disease. / Koshino, Akihiko; Schechter, Meir; Chertow, Glenn M; Vart, Priya; Jongs, Niels; Toto, Robert D; Rossing, Peter; Correa-Rotter, Ricardo; McMurray, John J V; Górriz, Jose Luis; Isidto, Rey; Kashihara, Naoki; Langkilde, Anna Maria; Wheeler, David C; Heerspink, Hiddo J L.
I: NEJM Evidence, Bind 2, Nr. 6, 2023.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Dapagliflozin and Anemia in Patients with Chronic Kidney Disease
AU - Koshino, Akihiko
AU - Schechter, Meir
AU - Chertow, Glenn M
AU - Vart, Priya
AU - Jongs, Niels
AU - Toto, Robert D
AU - Rossing, Peter
AU - Correa-Rotter, Ricardo
AU - McMurray, John J V
AU - Górriz, Jose Luis
AU - Isidto, Rey
AU - Kashihara, Naoki
AU - Langkilde, Anna Maria
AU - Wheeler, David C
AU - Heerspink, Hiddo J L
PY - 2023
Y1 - 2023
N2 - DAPA and Anemia in Patients with CKDThis post hoc analysis of the DAPA-CKD (Dapagliflozin in Patients with Chronic Kidney Disease) trial assessed the impact of dapagliflozin treatment on the correction and prevention of anemia. Results over a 2.4-year median follow-up show that dapagliflozin is associated with increase in hematocrit, correction of anemia, and reduced risk of incident anemia in patients with CKD with or without type 2 diabetes.
AB - DAPA and Anemia in Patients with CKDThis post hoc analysis of the DAPA-CKD (Dapagliflozin in Patients with Chronic Kidney Disease) trial assessed the impact of dapagliflozin treatment on the correction and prevention of anemia. Results over a 2.4-year median follow-up show that dapagliflozin is associated with increase in hematocrit, correction of anemia, and reduced risk of incident anemia in patients with CKD with or without type 2 diabetes.
KW - Humans
KW - Anemia
KW - Benzhydryl Compounds
KW - Diabetes Mellitus, Type 2
KW - Glucosides
KW - Renal Insufficiency, Chronic
U2 - 10.1056/EVIDoa2300049
DO - 10.1056/EVIDoa2300049
M3 - Journal article
C2 - 38320128
VL - 2
JO - NEJM Evidence
JF - NEJM Evidence
SN - 2766-5526
IS - 6
ER -
ID: 385016525